AGILE THERAPEUTICS INC·4

Feb 10, 5:16 PM ET

AGILE THERAPEUTICS INC 4

4 · AGILE THERAPEUTICS INC · Filed Feb 10, 2016

Insider Transaction Report

Form 4
Period: 2016-02-08
MacFarlane Katie
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2016-02-08+35,00035,000 total
    Exercise: $5.93Exp: 2026-02-07Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]This option was granted on February 8, 2016. 25% of the shares subject to the stock option vest on February 8, 2017, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on February 8, 2020.

Documents

1 file
  • 4
    a4.xmlPrimary

    4